247 related articles for article (PubMed ID: 16698729)
1. A 'best practices' approach to neuropathologic assessment in developmental neurotoxicity testing--for today.
Bolon B; Garman R; Jensen K; Krinke G; Stuart B;
Toxicol Pathol; 2006; 34(3):296-313. PubMed ID: 16698729
[TBL] [Abstract][Full Text] [Related]
2. Developmental neuropathology in DNT-studies--a sensitive tool for the detection and characterization of developmental neurotoxicants.
Kaufmann W; Gröters S
Reprod Toxicol; 2006 Aug; 22(2):196-213. PubMed ID: 16781841
[TBL] [Abstract][Full Text] [Related]
3. The need for developmental neurotoxicity studies in risk assessment for developmental toxicity.
Hass U
Reprod Toxicol; 2006 Aug; 22(2):148-56. PubMed ID: 16777374
[TBL] [Abstract][Full Text] [Related]
4. A qualitative retrospective analysis of positive control data in developmental neurotoxicity studies.
Crofton KM; Makris SL; Sette WF; Mendez E; Raffaele KC
Neurotoxicol Teratol; 2004; 26(3):345-52. PubMed ID: 15113596
[TBL] [Abstract][Full Text] [Related]
5. Neuropathology standards: what constitutes an optimal histomorphologic evaluation of the nervous system in general toxicity studies.
Houle CD
Toxicol Pathol; 2011 Oct; 39(6):1010-2. PubMed ID: 21859885
[TBL] [Abstract][Full Text] [Related]
6. Undertaking positive control studies as part of developmental neurotoxicity testing: a report from the ILSI Research Foundation/Risk Science Institute expert working group on neurodevelopmental endpoints.
Crofton KM; Foss JA; Hass U; Jensen KF; Levin ED; Parker SP
Neurotoxicol Teratol; 2008; 30(4):266-87. PubMed ID: 17681747
[TBL] [Abstract][Full Text] [Related]
7. Continuing education course #3: current practices and future trends in neuropathology assessment for developmental neurotoxicity testing.
Bolon B; Garman RH; Gundersen HJ; Allan Johnson G; Kaufmann W; Krinke G; Little PB; Makris SL; Mellon RD; Sulik KK; Jensen K
Toxicol Pathol; 2011 Jan; 39(1):289-93. PubMed ID: 21075916
[TBL] [Abstract][Full Text] [Related]
8. Current problems of in vivo developmental neurotoxicity tests and a new in vivo approach focusing on each step of the developing central nervous system.
Kuwagata M
Congenit Anom (Kyoto); 2012 Sep; 52(3):129-39. PubMed ID: 22925213
[TBL] [Abstract][Full Text] [Related]
9. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
10. Introduction to the ILSI Research Foundation/Risk Science Institute reports from the expert working group on neurodevelopmental endpoints.
Fitzpatrick J; Mendez E; Walls I
Neurotoxicol Teratol; 2008; 30(4):263-5. PubMed ID: 18407461
[TBL] [Abstract][Full Text] [Related]
11. Comments from the Developmental Neurotoxicology Committee of the Japanese Teratology Society on the OECD Guideline for the Testing of Chemicals, Proposal for a New Guideline 426, Developmental Neurotoxicity Study, Draft Document (October 2006 version), and on the Draft Document of the Retrospective Performance Assessment of the Draft Test Guideline 426 on Developmental Neurotoxicity.
Ema M; Fukui Y; Aoyama H; Fujiwara M; Fuji J; Inouye M; Iwase T; Kihara T; Oi A; Otani H; Shinomiya M; Sugioka K; Yamano T; Yamashita KH; Tanimura T;
Congenit Anom (Kyoto); 2007 Jun; 47(2):74-6. PubMed ID: 17504392
[TBL] [Abstract][Full Text] [Related]
12. Compilation of international regulatory guidance documents for neuropathology assessment during nonclinical general toxicity and specialized neurotoxicity studies.
Bolon B; Bradley A; Butt M; Jensen K; Krinke G; Mellon RD
Toxicol Pathol; 2011 Jan; 39(1):92-6. PubMed ID: 21119055
[TBL] [Abstract][Full Text] [Related]
13. Statistical issues and techniques appropriate for developmental neurotoxicity testing: a report from the ILSI Research Foundation/Risk Science Institute expert working group on neurodevelopmental endpoints.
Holson RR; Freshwater L; Maurissen JP; Moser VC; Phang W
Neurotoxicol Teratol; 2008; 30(4):326-48. PubMed ID: 17681748
[TBL] [Abstract][Full Text] [Related]
14. STP position paper: Recommended practices for sampling and processing the nervous system (brain, spinal cord, nerve, and eye) during nonclinical general toxicity studies.
Bolon B; Garman RH; Pardo ID; Jensen K; Sills RC; Roulois A; Radovsky A; Bradley A; Andrews-Jones L; Butt M; Gumprecht L
Toxicol Pathol; 2013; 41(7):1028-48. PubMed ID: 23475559
[TBL] [Abstract][Full Text] [Related]
15. Bromate: concern for developmental neurotoxicity?
Crofton KM
Toxicology; 2006 Apr; 221(2-3):212-6. PubMed ID: 16516369
[TBL] [Abstract][Full Text] [Related]
16. Modern pathology methods for neural investigations.
Hale SL; Andrews-Jones L; Jordan WH; Jortner BS; Boyce RW; Boyce JT; Switzer RC; Butt MT; Garman RH; Jensen K; Krinke G; Little PB
Toxicol Pathol; 2011 Jan; 39(1):52-7. PubMed ID: 21212254
[TBL] [Abstract][Full Text] [Related]
17. Recommendations for harmonization of data collection and analysis of developmental neurotoxicity endpoints in regulatory guideline studies: Proceedings of workshops presented at Society of Toxicology and joint Teratology Society and Neurobehavioral Teratology Society meetings.
Li AA; Sheets LP; Raffaele K; Moser V; Hofstra A; Hoberman A; Makris SL; Garman R; Bolon B; Kaufmann W; Auer R; Lau E; Vidmar T; Bowers WJ
Neurotoxicol Teratol; 2017 Sep; 63():24-45. PubMed ID: 28757310
[TBL] [Abstract][Full Text] [Related]
18. Identification and interpretation of developmental neurotoxicity effects: a report from the ILSI Research Foundation/Risk Science Institute expert working group on neurodevelopmental endpoints.
Tyl RW; Crofton K; Moretto A; Moser V; Sheets LP; Sobotka TJ
Neurotoxicol Teratol; 2008; 30(4):349-81. PubMed ID: 17826946
[TBL] [Abstract][Full Text] [Related]
19. Best practices for clinical pathology testing in carcinogenicity studies.
Young JK; Hall RL; O'Brien P; Strauss V; Vahle JL
Toxicol Pathol; 2011 Feb; 39(2):429-34. PubMed ID: 21297067
[TBL] [Abstract][Full Text] [Related]
20. Analysis and integration of developmental neurotoxicity and ancillary data into risk assessment: a case study of dimethoate.
DeSesso JM; Watson RE; Keen CL; Hazelden KP; Haws LC; Li AA
J Toxicol Environ Health A; 2009; 72(2):94-109. PubMed ID: 19034799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
